Marrero JA - Search Results

1

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease.

Fujiwara N, Kubota N, Crouchet E, Koneru B, Marquez CA, Jajoriya AK, Panda G, Qian T, Zhu S, Goossens N, Wang X, Liang S, Zhong Z, Lewis S, Taouli B, Schwartz ME, Fiel MI, Singal AG, Marrero JA, Fobar AJ, Parikh ND, Raman I, Li QZ, Taguri M, Ono A, Aikata H, Nakahara T, Nakagawa H, Matsushita Y, Tateishi R, Koike K, Kobayashi M, Higashi T, Nakagawa S, Yamashita YI, Beppu T, Baba H, Kumada H, Chayama K, Baumert TF, Hoshida Y. Fujiwara N, et al. Among authors: marrero ja. Sci Transl Med. 2022 Jun 22;14(650):eabo4474. doi: 10.1126/scitranslmed.abo4474. Epub 2022 Jun 22. Sci Transl Med. 2022. PMID: 35731891 Free PMC article.

2

NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. Marrero JA, et al. Hepatology. 2002 Dec;36(6):1349-54. doi: 10.1053/jhep.2002.36939. Hepatology. 2002. PMID: 12447858 Free article.

3

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Marrero JA, et al. Hepatology. 2003 May;37(5):1114-21. doi: 10.1053/jhep.2003.50195. Hepatology. 2003. PMID: 12717392

4

Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.

Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Marrero JA, et al. Liver Transpl. 2005 Mar;11(3):281-9. doi: 10.1002/lt.20357. Liver Transpl. 2005. PMID: 15719410 Free article. Clinical Trial.

5

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS. Marrero JA, et al. Hepatology. 2005 Apr;41(4):707-16. doi: 10.1002/hep.20636. Hepatology. 2005. PMID: 15795889 Free article.

6

Hepatocellular carcinoma.

Marrero JA. Marrero JA. Curr Opin Gastroenterol. 2005 May;21(3):308-12. doi: 10.1097/01.mog.0000159817.55661.ca. Curr Opin Gastroenterol. 2005. PMID: 15818151 Review.

7

Hepatocellular carcinoma.

Marrero JA. Marrero JA. Curr Opin Gastroenterol. 2006 May;22(3):248-53. doi: 10.1097/01.mog.0000218961.86182.8c. Curr Opin Gastroenterol. 2006. PMID: 16550039 Review.

8

Hepatocellular carcinoma.

Marrero JA, Pelletier S. Marrero JA, et al. Clin Liver Dis. 2006 May;10(2):339-51, ix. doi: 10.1016/j.cld.2006.05.012. Clin Liver Dis. 2006. PMID: 16971265 Review.

9

Role of liver transplantation in the treatment of cholangiocarcinoma.

Singal A, Welling TH, Marrero JA. Singal A, et al. Among authors: marrero ja. Expert Rev Anticancer Ther. 2009 Apr;9(4):491-502. doi: 10.1586/era.09.5. Expert Rev Anticancer Ther. 2009. PMID: 19374602 Review.

10

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, Marrero JA. Singal A, et al. Among authors: marrero ja. Aliment Pharmacol Ther. 2009 Jul;30(1):37-47. doi: 10.1111/j.1365-2036.2009.04014.x. Epub 2009 Apr 8. Aliment Pharmacol Ther. 2009. PMID: 19392863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results